| Product Code: ETC8543794 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Neurological Disorder Drugs Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Neurological Disorder Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Neurological Disorder Drugs Market - Industry Life Cycle |
3.4 Netherlands Neurological Disorder Drugs Market - Porter's Five Forces |
3.5 Netherlands Neurological Disorder Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Netherlands Neurological Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Netherlands Neurological Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Netherlands Neurological Disorder Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Netherlands Neurological Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Neurological Disorder Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in the Netherlands |
4.2.2 Technological advancements in drug development for neurological disorders |
4.2.3 Growing awareness and focus on mental health and neurological disorders in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in the Netherlands |
4.3.2 High cost of research and development for neurological disorder drugs |
4.3.3 Competition from alternative therapies and treatments |
5 Netherlands Neurological Disorder Drugs Market Trends |
6 Netherlands Neurological Disorder Drugs Market, By Types |
6.1 Netherlands Neurological Disorder Drugs Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.5 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.6 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.7 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Cerebrovascular Disease, 2021- 2031F |
6.1.8 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Neurological Disorder Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By NMDA Receptor Antagonists, 2021- 2031F |
6.2.4 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Antiepileptic, 2021- 2031F |
6.2.5 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Antipsychotic and Antidepressant, 2021- 2031F |
6.2.6 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Neurological Disorder Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Neurological Disorder Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Neurological Disorder Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Netherlands Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Neurological Disorder Drugs Market Import-Export Trade Statistics |
7.1 Netherlands Neurological Disorder Drugs Market Export to Major Countries |
7.2 Netherlands Neurological Disorder Drugs Market Imports from Major Countries |
8 Netherlands Neurological Disorder Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for neurological disorder drugs in the Netherlands |
8.2 Percentage of healthcare professionals trained in diagnosing and treating neurological disorders |
8.3 Investments in research and development for innovative neurological disorder drugs |
8.4 Adoption rate of new neurological disorder drugs in the market |
9 Netherlands Neurological Disorder Drugs Market - Opportunity Assessment |
9.1 Netherlands Neurological Disorder Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Netherlands Neurological Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Netherlands Neurological Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Netherlands Neurological Disorder Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Netherlands Neurological Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Neurological Disorder Drugs Market - Competitive Landscape |
10.1 Netherlands Neurological Disorder Drugs Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Neurological Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here